Michael Floyd - 22 Jun 2021 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Operating Officer
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
22 Jun 2021
Transactions value $
$14,058
Form type
4
Filing time
22 Jun 2021, 18:07:57 UTC
Previous filing
10 Jun 2021
Next filing
09 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Purchase $14,058 +2,000 +7.7% $7.03 28,000 22 Jun 2021 Direct
holding PCSA Common Stock 103,851 22 Jun 2021 by Elion Oncology, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.